Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
FBIO Fortress Biotech Inc
- Stocks
- Healthcare
- NASDAQ: FBIO
Price (delayed)
$1.815
Market cap
$53.67M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.23
Enterprise value
$35.35M
Fortress Biotech, Inc. ("Fortress") is an innovative biopharmaceutical company that was ranked in Deloitte's 2019 and 2020 Technology Fast 500™, annual rankings of the fastest- growing North American companies in
Highlights
Fortress Biotech's EPS has surged by 64% YoY and by 17% QoQ
FBIO's quick ratio has soared by 56% QoQ and by 39% YoY
The gross profit has declined by 38% year-on-year but it has increased by 6% since the previous quarter
FBIO's gross margin is down by 8% YoY but it is up by 6% QoQ
FBIO's revenue is down by 32% year-on-year
The company's equity fell by 3.4% YoY and by 2.1% QoQ
Key stats
What are the main financial stats of FBIO
Market
Valuations
Earnings
Shares outstanding
29.57M
Market cap
$53.67M
Enterprise value
$35.35M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.41
Price to sales (P/S)
0.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.61
Revenue
$57.78M
Gross profit
$38.93M
Operating income
-$96.04M
Net income
-$41.16M
EBIT
-$27.03M
EBITDA
-$19.76M
Free cash flow
-$73.2M
Per share
Balance sheet
Liquidity
EPS
-$2.23
EPS diluted
-$2.23
Free cash flow per share
-$2.77
Book value per share
$0.75
Revenue per share
$2.18
TBVPS
$5.57
Total assets
$178.07M
Total liabilities
$145.59M
Debt
$74.24M
Equity
$22.25M
Working capital
$53.23M
Debt to equity
3.34
Current ratio
1.72
Quick ratio
1.51
Net debt/EBITDA
0.93
Margins
Efficiency
Dividend
EBITDA margin
-34.2%
Gross margin
67.4%
Net margin
-71.2%
Operating margin
-166.2%
Return on assets
-34.1%
Return on equity
-241.6%
Return on invested capital
-49.2%
Return on capital employed
-25.9%
Return on sales
-46.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
FBIO stock price
How has the Fortress Biotech stock price performed over time
Intraday
-0.82%
1 week
-13.57%
1 month
0.28%
1 year
1.4%
YTD
-10.37%
QTD
16.35%
Financial performance
How have Fortress Biotech's revenue and profit performed over time
Revenue
$57.78M
Gross profit
$38.93M
Operating income
-$96.04M
Net income
-$41.16M
Gross margin
67.4%
Net margin
-71.2%
The gross profit has declined by 38% year-on-year but it has increased by 6% since the previous quarter
FBIO's revenue is down by 32% year-on-year
FBIO's net income is up by 24% YoY and by 11% QoQ
FBIO's operating income is up by 20% YoY and by 13% from the previous quarter
Price vs fundamentals
How does FBIO's price correlate with its fundamentals
Growth
What is Fortress Biotech's growth rate over time
Valuation
What is Fortress Biotech stock price valuation
P/E
N/A
P/B
2.41
P/S
0.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.61
Fortress Biotech's EPS has surged by 64% YoY and by 17% QoQ
The P/B is 22% more than the last 4 quarters average of 2.0
The company's equity fell by 3.4% YoY and by 2.1% QoQ
The P/S is 63% below the 5-year quarterly average of 2.3 but 40% above the last 4 quarters average of 0.6
FBIO's revenue is down by 32% year-on-year
Efficiency
How efficient is Fortress Biotech business performance
FBIO's return on invested capital is up by 48% year-on-year and by 15% since the previous quarter
The company's return on equity rose by 23% YoY and by 8% QoQ
Fortress Biotech's return on sales has increased by 16% QoQ
The ROA has grown by 11% since the previous quarter and by 10% year-on-year
Dividends
What is FBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for FBIO.
Financial health
How did Fortress Biotech financials performed over time
The total assets is 22% more than the total liabilities
FBIO's quick ratio has soared by 56% QoQ and by 39% YoY
Fortress Biotech's current ratio has increased by 35% from the previous quarter and by 29% YoY
The debt has decreased by 13% YoY
The debt to equity has declined by 10% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.